Lung cancer: from single-gene methylation to methylome profiling

Cancer Metastasis Reviews
Gerwin HellerSabine Zöchbauer-Müller

Abstract

DNA methylation as part of the epigenetic gene-silencing complex is a universal occurring change in lung cancer. Numerous studies investigated methylation of specific genes in primary tumors, in serum or plasma samples, and in specimens from the aerodigestive tract epithelium of lung cancer patients. In most studies, single genes or small numbers of genes were analyzed. Moreover, it has been observed that methylation of certain genes can already be detected in samples from the upper aerodigestive tract epithelium of cancer-free heavy smokers. These findings indicated that methylation of certain genes may be a useful biomarker for prognosis, disease recurrence, early detection, and lung cancer risk assessment. So far, several genes were identified which seem to be of worse prognostic relevance when they were found to be methylated. In addition, it has been shown that a panel of markers may be relevant to predict disease recurrence after surgery. In comparison to analysis of single or small numbers of genes, methods for genome-wide detection of methylation were developed recently. These approaches are focused on either pharmacological re-activation of methylated genes followed by expression microarray analysis or on microarray an...Continue Reading

References

Jul 20, 1987·Journal of Molecular Biology·M Gardiner-Garden, M Frommer
Nov 15, 1994·International Journal of Cancer. Journal International Du Cancer·D M ParkinE Masuyer
Jan 1, 1995·Cancer·W D TravisS S Devesa
Nov 1, 1993·Somatic Cell and Molecular Genetics·K MatsuoW Schaffner
May 20, 1994·Cell·A Razin, H Cedar
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jun 30, 1998·International Journal of Cancer. Journal International Du Cancer·K KashiwabaraT Nakajima
Sep 11, 1998·Nature·S EdenA W Thorne
Mar 2, 1999·Journal of the National Cancer Institute·S A AhrendtD Sidransky
Aug 17, 2000·Journal of the National Cancer Institute·A K VirmaniA F Gazdar
Sep 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M KerstingM Schuermann
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Mar 30, 2001·Nature Genetics·M KuramochiY Murakami
May 3, 2001·Journal of the National Cancer Institute·D G BurbeeJ D Minna
Sep 26, 2001·Neoplasia : an International Journal for Oncology Research·Z DaiC Plass
Sep 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michiho NishiokaJun Yokota
Sep 20, 2002·BioTechniques·Mario F Fraga, Manel Esteller
Nov 28, 2002·International Journal of Cancer. Journal International Du Cancer·Shinichi ToyookaAdi F Gazdar
May 2, 2003·Annals of the New York Academy of Sciences·Timothy H Bestor
Jun 12, 2003·International Journal of Cancer. Journal International Du Cancer·Arvind VirmaniAdi F Gazdar
Aug 13, 2003·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shinichi ToyookaAdi F Gazdar
Aug 20, 2003·International Journal of Cancer. Journal International Du Cancer·Hongbing ShenQingyi Wei
Oct 2, 2003·International Journal of Cancer. Journal International Du Cancer·Sabine Zöchbauer-MüllerAdi F Gazdar
Feb 7, 2004·Bioinformatics·Yong Wang, Frederick C C Leung
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Shinichi ToyookaAdi F Gazdar
May 18, 2004·International Journal of Cancer. Journal International Du Cancer·Hans J GroteMario Sarbia
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hojoong KimDuk-Hwan Kim
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Jun 29, 2004·The Journal of Biological Chemistry·Jesus EspadaManel Esteller
Jul 22, 2004·British Journal of Cancer·S ToyookaA F Gazdar
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles LuFadlo R Khuri
Dec 21, 2004·Genomics·Todd C MocklerJoseph R Ecker

❮ Previous
Next ❯

Citations

Mar 23, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jing WenMing Guo
Apr 24, 2012·DNA and Cell Biology·Lauren P Blair, Qin Yan
Nov 23, 2012·Carcinogenesis·Gerwin HellerSabine Zöchbauer-Müller
Jul 30, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Frank BoellmannRussell S Thomas
Nov 2, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Humam KadaraIgnacio I Wistuba
Jun 4, 2011·Molekuliarnaia biologiia·A A PonomarevaV V Vlasov
May 21, 2011·American Journal of Respiratory and Critical Care Medicine·Ivana V Yang, David A Schwartz
Jun 16, 2012·American Journal of Respiratory and Critical Care Medicine·Yan Y SandersJames S Hagood
Sep 21, 2010·Journal of Translational Medicine·Mónica CastroMarta Sánchez-Carbayo
May 3, 2012·Proceedings of the American Thoracic Society·Humam Kadara, Ignacio I Wistuba
Feb 8, 2013·Biomarkers in Medicine·Ioanna BalgkouranidouEvi S Lianidou
Mar 1, 2014·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·J CorralesK L Willett
Jul 3, 2015·Oncology Reports·Takashi SatoTomoko Betsuyaku
Mar 26, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Rejane Hughes CarvalhoSjaak Philipsen
Oct 21, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yong-Jae KwonJong Ho Park
Jan 1, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jong Y ParkSeung Joon Kim
Nov 3, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Anne-Marie BairdSteven G Gray
Nov 8, 2011·Clinics in Chest Medicine·Jill E Larsen, John D Minna
Feb 12, 2013·Translational Oncology·Alice PasiniDaniele Calistri
Oct 1, 2011·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Fang Lu, Hong-Tao Zhang
Apr 2, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Scott M LangevinKarl T Kelsey
Apr 9, 2016·Briefings in Functional Genomics·Shicai Fan, Wenming Chi
Apr 14, 2016·Journal of Cancer Research and Therapeutics·Ji-Chang HanZhong-Sen Ma
Sep 10, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Larissa A PikorWan L Lam
May 14, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anne-Marie BairdKenneth J O'Byrne
Apr 24, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Heather H NelsonKarl T Kelsey
Oct 12, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Stella TommasiAhmad Besaratinia
Jan 18, 2017·Molecular Cancer·Corinna AltenbergerSabine Zöchbauer-Müller
Jan 1, 2011·Cancers·Kenneth J O'ByrneSteven G Gray
Mar 24, 2018·The Journal of Pathology·Gerwin HellerSabine Zöchbauer-Müller
May 3, 2019·Technology and Health Care : Official Journal of the European Society for Engineering and Medicine·Dan Yang, Hanming Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.